MYGN Earnings

Quarterly EPS
$-0.24
Q3 2024
$-0.47
Q4 2024
$0.00
Q1 2025
$-3.57
Q2 2025
$-0.29
Q3 2025
$-0.08
Q4 2025
$-0.36
Q1 2026
$-0.46
Q2 2026
Latest Revenue190.7M
Latest Net Income-43200000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.46190.7M-43200000-10.5%+87.1%
Q1 2026-$0.36200.4M-34100000+2.3%
Q4 2025-$0.08209.8M-7900000-0.4%+83.0%
Q3 2025-$0.29205.7M-27400000-3.6%-20.8%
Q2 2025-$3.57213.1M-330500000+0.8%-770.7%
Q1 2025$0.00195.9M-100000-3.1%+100.0%
Q4 2024-$0.47210.6M-42500000+7.1%-30.6%
Q3 2024-$0.24213.3M-22100000+11.2%+68.0%
Q2 2024-$0.41211.5M-36700000
Q1 2024-$0.29202.2M-26000000
Q4 2023-$0.36196.6M-31200000
Q3 2023-$0.75191.9M-61300000
Myriad Genetics (MYGN) — Earnings